Infectious diseases and vaccine sciences: Strategic directions

Journal of Health, Population and Nutrition

Volumn 26, Issue 3, 2008, Pages 295-310

  Luby, Stephen P ^a   Brooks, W Abdullah ^a   Zaman, K ^a   Hossain, Shahed ^a   Ahmed, Tahmeed ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

Bangladesh; Communicable diseases; Diarrhoea; Mortality; Pneumoniea; Tuberculosis; Vaccine Sciences

Indexed keywords

HAEMOPHILUS INFLUENZAE; ROTAVIRUS; STREPTOCOCCUS PNEUMONIAE;

BANGLADESH; CHILDHOOD MORTALITY; COMMUNICABLE DISEASE; DIARRHEA; FEMALE; HUMAN; INFANT; INFECTION CONTROL; MALE; METHODOLOGY; MORTALITY; NEWBORN; PNEUMONIA; PRESCHOOL CHILD; PRIMARY PREVENTION; REVIEW; TUBERCULOSIS; VACCINATION;

BANGLADESH; CHILD MORTALITY; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DIARRHEA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PNEUMONIA; PRIMARY PREVENTION; TUBERCULOSIS; VACCINATION;

EID: 54549114518     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (93)

1. Salway SM, Nasim SM. Levels, trends and causes of mortality in children below 5 years of age in Bangladesh: findings from a national survey. J Diarrhoeal Dis Res 1994;12:187-93.
2. National Institute of Population Research and Training. Bangladesh demographic and health survey 2004. Dhaka: National Institute of Population Research and Training, 2005. 342 p.
3. Chen LC, Rahman M, Sarder AM. Epidemiology and causes of death among children in a rural area of Bangladesh. Int J Epidemiol 1980;9:25-33.
4. Bhatia S. Patterns and causes of neonatal and post-neonatal mortality in rural Bangladesh. Stud Fam Plann 1989;20:136-46.
5. Black RE, Huber DH, Curlin GT. Reduction of neonatal tetanus by mass immunization of non-pregnant women: duration of protection provided by one or two doses of aluminium-adsorbed tetanus toxoid. Bull World Health Organ 1980;58:927-30.
6. Koenig MA, Roy NC, McElrath T, Shahidullah M, Wojtyniak B. Duration of protective immunity conferred by maternal tetanus toxoid immunization: further evidence from Matlab, Bangladesh. Am J Public Health 1998;88:903-7.
7. Clemens JD, Stanton BF, Chakraborty J, Chowdhury S, Rao MR, Ali M et al. Measles vaccination and childhood mortality in rural Bangladesh. Am J Epidemiol 1988;128:1330-9.
8. Koenig MA, Khan MA, Wojtyniak B, Clemens JD, Chakraborty J, Fauveau V et al. Impact of measles vaccination on childhood mortality in rural Bangladesh. Bull World Health Organ 1990;68:441-7.
9. Rahaman MM, Aziz KM, Patwari Y, Munshi MH. Diarrhoeal mortality in two Bangladeshi villages with and without community-based oral rehydration therapy. Lancet 1979;2:809-12.
10. West KP, Jr., Pokhrel RP, Katz J, LeClerq SC, Khatry SK, Shrestha SR et al. Efficacy of vitamin A in reducing preschool child mortality in Nepal. Lancet 1991;338:67-71.
11. Humphrey JH, Agoestina T, Wu L, Usman A, Nurachim M, Subardja D et al. Impact of neonatal vitamin A supplementation on infant morbidity and mortality. J Pediatr 1996;128:489-96.
12. Baqui AH, Sabir AA, Begum N, Arifeen SE, Mitra SN, Black RE. Causes of childhood deaths in Bangladesh: an update. Acta Paediatr 2001;90:682-90.
13. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2006. Geneva: World Health Organization, 2006:242. (WHO/HTM/TB/2006.362).
14. Arifeen SE, Akhter T, Chowdhury HR, Rahman KM, Chowdhury EK, Alam N et al. Causes of death in children under five years of age. In: Bangladesh Demographic and Health Survey 2004. Dhaka: National Institute of Population Research and Training, 2005:125-33.
15. Potential for epidemic dysentery in Bangladesh, associated with the emergence of multi-drug resistant Shigella dysenteriae type 1, resistant to ciprofloxacin. Health Sci Bull 2003;1:15-6.
16. Emergence of a unique, multi-drug resistant stratin of Vibrio cholerae 01 in Bangladesh. Health Sci Bull 2005;3:1-4.
17. World Bank. World development report 2007: development and the next generation. Washington, DC: World Bank, 2006:288-90.
18. Ahmed T, Roy SK, Alam N, Ahmed AMSS, Ara G, Bhuiya AU et al. Baseline survey 2004 of National Nutrition Programme: report. Dhaka: International Centre for Diarrhoeal Disease Research, Bangladesh, 2005. 319 p. (ICDDR,B special publication no. 124).
19. Luby SP, Agboatwalla M, Painter J, Altaf A, Billhimer WL, Hoekstra RM. Effect of intensive handwashing promotion on childhood diarrhea in high-risk communities in Pakistan: a randomized controlled trial. JAMA 2004;291:2547-54.
20. Yoon PW, Black RE, Moulton LH, Becker S. The effect of malnutrition on the risk of diarrheal and respiratory mortality in children < 2 y of age in Cebu, Philippines. Am J Clin Nutr 1997;65:1070-7.
21. Sachdev HP, Kumar S, Singh KK, Satyanarayana L, Puri RK. Risk factors for fatal diarrhea in hospitalized children in India. J Pediatr Gastroenterol Nutr 1991;12:76-81.
22. Trends in aetiologies for dianhoeal diseases. Health Sci Bull 2002;1:12-5.
23. Qadri F, Khan AI, Faruque AS, Begum YA, Chowdhury F, Nair GB et al. Enterotoxigenic Escherichia coli and Vibrio cholerae diarrhea, Bangladesh, 2004. Emerg Infect Dis 2005; 11:1104-7.
24. Qadri F, Svennerholm AM, Faruque AS, Sack RB. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention. Clin Microbiol Rev 2005;18:465-83.
25. Tanaka G, Faruque ASG, Luby SP, Malek MA, Glass RI, Parasbar UD. Deaths from rotavirus in Bangladeshi children: estimates from hospital-based surveillance. Pediatric Infect Dis J 2007;26:1014-9.
26. Vesikari T, Matson DO, Dennehy P, Van DP, Santosham M, Rodriguez Z et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33.
27. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22.
28. Qadri F, Chowdhury MI, Faruque SM, Salam MA, Ahmed T, Begum YA et al. Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh. J Infect Dis 2005;192:573-9.
29. Clemens JD, Sack DA, Harris JR, van LF, Chakraborty J, Ahmed F et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 1990;335:270-3.
30. Ali M, Emch M, von SL, Yunus M, Sack DA, Rao M et al. Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet 2005;366:44-9.
31. Qadri F, Ahmed T, Ahmed F, Begum YA, Sack DA, Svennerholm AM. Reduced doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infant 6-17 months of age: dosing studies in different age groups. Vaccine 2006;24:1726-33.
32. Khan MU. Interruption of shigellosis by hand washing. Trans R Soc Trop Med Hyg 1982;76:164-8.
33. Stanton BF, Clemens JD. An educational intervention for altering water-sanitation behaviors to reduce childhood diarrhea in urban Bangladesh. II. A randomized trial to assess the impact of the intervention on hygienic behaviors and rates of diarrhea. Am J Epidemiol 1987;125:292-301.
34. Shahid NS, Greenough WB, III, Samadi AR, Huq MI, Rahman N. Hand washing with soap reduces diarrhoea and spread of bacterial pathogens in a Bangladesh village. J Diarrhoeal Dis Res 1996;14:85-9.
35. Curtis V, Cairncross S. Effect of washing hands with soap on diarrhoea risk in the community: a systematic review. Lancet Infect Dis 2003;3:275-81.
36. Clasen T, Schmidt WP, Rabie T, Roberts I, Cairncross S. Interventions to improve water quality for preventing diarrhoea: systematic review and meta-analysis. BMJ (Clinical research ed) 2007;334:782.
37. Luby SP, Mendoza C, Keswick BH, Chiller T, Hoekstra RM. Difficulties in bringing point-of-use water treatment to scale in rural Guatemala. Am J Trop Med Hyg 2008;78:382-7.
38. Rabbani GH, Teka T, Saha SK, Zaman B, Majid N, Khatun M et al. Green banana and pectin improve small intestinal permeability and reduce fluid loss in Bangladeshi children with persistent diarrhea. Dig Dis Sci 2004;49:475-84.
39. Bryce J, Boschi-Pinto C, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet 2005;365:1147-52.
40. Rahman M, Huq F, Sack DA, Butler T, Azad AK, Alam A et al. Acute lower respiratory tract infections in hospitalized patients with diarrhea in Dhaka, Bangladesh. Rev Infect Dis 1990;12(Suppl 8):S899-S906.
41. Huq F, Rahman M, Nahar N, Alam A, Haque M, Sack DA et al. Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh. Rev Infect Dis 1990;12(Suppl 8):S982-S7.
42. Nicholson KG, McNally T, Silverman M, Simons P, Stockton JD, Zambon MC. Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children. Vaccine 2006;24:102-8.
43. Mulholland EK, Ogunlesi OO, Adegbola RA, Weber M, Sam BE, Palmer A et al. Etiology of serious infections in young Gambian infants. Pediatr Infect Dis J 1999;18(10 Suppl):S35-S41.
44. Forgie IM, O'Neill KP, Lloyd-Evans N, Leinonen M, Campbell H, Whittle HC et al. Etiology of acute lower respiratory tract infections in Gamblan children: I. Acute lower respiratory tract infections in Infants presenting at the hospital. Pediatr Infect Dis J 1991;10:33-41.
45. Dagan R, Hall CB. Influenza A virus infection imitating bacterial sepsis in early infancy. Pediatr Infect Dis 1984;3:218-21.
46. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9.
47. McCullers JA, Facchini S, Chesney PJ, Webster RG. Influenza B virus encephalitis. Clin Infect Dis 1999; 28:898-900.
48. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Jr., Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-31.
49. O'Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 2000;30:784-9.
50. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003;187:1000-9.
51. Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005; 366:144-50.
52. Klugman KP. Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections. Eur Respir J 2002;36 (Suppl):3S-8S.
53. Mandell LA, Peterson LR, Wise R, Hooper D, Low DE, Schaad UB et al. The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? Clin Infect Dis 2002;35:721-7.
54. Morita JY, Zell ER, Danila R, Farley MM, Hadler J, Harrison LH et al. Association between antimicrobial resistance among pneumococcal isotates and burden of invasive pneumococcal disease in the community. Clin Infect Dis 2002;35:420-7.
55. Jacobs MR. Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr Infect Dis J 2003;22(8 Suppl):S109-S19.
56. Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) Pneumonia Study Group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002;360:835-41.
57. Brooks WA, Yunus M, Santosham M, Wahed MA, Nahar K, Yeasmin S et al. Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial. Lancet 2004;363:1683-8.
58. Gessner BD, Sutanto A, Linehan M, Djelantik IG, Fletcher T, Gerudug IK et al. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet 2005;365:43-52.
59. Lagos R, Levine OS, Avendano A, Horwitz I, Levine MM. The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries. Pediatr Infect Dis J 1998;17(Suppl 9):S139-S48.
60. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365:1139-46.
61. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003;349:1341-8.
62. Baqui AH, El Arifeen S, Saha SK, Persson L, Zaman K, Gessner BD et al. Effectiveness of Haemophilus influenzae type B conjugate vaccine on prevention of pneumonia and meningitis in Bangladeshi children: a case-control study. Pediatr Infect Dis J 2007;26:565-71.
63. Mulholland EK, Adegbola RA. The Gambian Haemophilus influenzae type b vaccine trial: what does it tell us about the burden of Haemophilus influenzae type b disease? Pediatr Infect Dis J 1998;17(9 Suppl):S123-S5.
64. Baqui AH, Black RE, El AS, Yunus M, Chakraborty J, Ahmed S et al. Effect of zinc supplementation started during diarrhoea on morbidity and mortality in Bangladeshi children: community randomised trial. BMJ 2002;325:1059.
65. Brooks WA, Santosham M, Roy SK, Faruque AS, Wahed MA, Nahar K et al. Efficacy of zinc in young infants with acute watery diarrhea. Am J Clin Nutr 2005;82:605-10.
66. Bhandari N, Bahl R, Taneja S, Strand T, Molbak K, Ulvik RJ, et al. Effect of routine zinc supplementation on pneumonia in children aged 6 months to 3 years: randomised controlled trial in an urban slum. BMJ 2002;324:1358.
67. Bhutta ZA, Black RE, Brown KH, Gardner JM, Gore S, Hidayat A et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr 1999;135:689-97.
68. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991;72:1-6.
69. Kaye K, Frieden TR. Tuberculosis control: the relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance. Epidemiol Rev 1996;18:52-63.
70. Fact sheets on tuberculosis. Dhaka: National Tuberculosis Control Programme, Directorate General of Health Services, Ministry of Health and Family Planning, Government of Bangladesh, 2005. 6 p.
71. National Tuberculosis Control and Research Project. The report of tuberculosis survey of Bangladesh. Dhaka: Ministry of Health and Family Planning, Government of Bangladesh, 1973. 157 p.
72. Bangladesh. Directorate General of Health Services. Report on the national prevalence. Survey on tuberculosis in Bangladesh, 1987-88. Dhaka: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of Bangladesh, 1989. 30 p.
73. Chowdhury AM, Chowdhury S, Islam MN, Islam A, Vaughan JP. Control of tuberculosis by community health workers in Bangladesh. Lancet 1997;350:169-72.
74. Salim MAH, Declercq E, Van DA, Saki KA. Gender differences in tuberculosis: a prevalence survey done in Bangladesh. Int J Tuberc Lung Dis 2004;8:952-7.
75. Zaman K, Yunus M, Arifeen SE, Baqui AH, Sack DA, Hossain S et al. 2006. Prevalence of sputum smear-positive tuberculosis in a rural area in Bangladesh. Epidemiol Infect 134:1052-9.
76. Zaman K, Rahim Z, Yunus M, Arifeen S, Baqui A, Sack D et al. Drug resistance of Mycobacteriwn tuberculosis in selected urban and rural areas in Bangladesh. Scand J Infect Dis 2005;37:21-6.
77. Nayar S, Narang P, Tyagi NK, Jajoo U, Dhage VR, Bharambe M. Field trial of short term intermittent chemotherapy of patients with pulmonary tuberculosis in Wardha district. Indian J Tubercul 1988;35:176-82.
78. Islam MN, Islam A, Mahmud SN. Impact of TB control project on prevalence of the disease in rural. Dhaka: Bangladesh Rural Advancement Committee, 1995. 15 p.
79. HIV surveillance in Bangladesh. Health Sci Bull 2003; 1:1-7.
80. Begum V, de CP, Das GS, Salim AH, Hussain H, Pietroni M et al. Tuberculosis and patient gender in Bangladesh: sex differences in diagnosis and treatment outcome. Int J Tuberc Lung Dis 2001;5:604-10.
81. Diwan VK, Thorson A. Sex, gender, and tuberculosis. Lancet 1999;353:1000-1.
82. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367:938-40.
83. Gupta PC, Pednekar MS, Parkin DM, Sankaranarayanan R. Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol 2005;34:1395-402.
84. Bannon MJ. BCG and tuberculosis. Arch Dis Child 1999;80:80-3.
85. National TB control programme of Bangladesh: review and strategic plan 2001-2005. Dhaka: Ministry of Health and Family Welfare, Government of Bangladesh, 2001.
86. Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 1976;57:275-99.
87. Hossain MR, Ali MS, Alam MN, Haq SA, Amin MR, Ali AKMA et al. Primary drug resistance pattern of M. tuberculosis: report of 101 cases (abstract). In: Abstracts: 20th Annual General Meeting and Scientific Seminar, Chest and Heart Association of Bangladesh, 1998. Dhaka: Chest and Heart Association of Bangladesh, 1998.
88. Van DA, Aung KJ, Chowdhury S, Saha S, Pankaj A, Ashraf A et al. Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens. Int J Tuberc Lung Dis 1999;3:143-8.
89. Banu S, Gordon SV, Palmer S, Islam MR, Ahmed S, Alam KM et al. Genotypic analysis of Mycobacterium tuberculosis in Bangladesh and prevalence of the Beijing strain. J Clin Microbiol 2004;42:674-82.
90. Gocmen A, Kiper N, Ertan U, Kalayci O, Ozcelik U. Is the BCG test of diagnostic value in tuberculosis? Tuber Lung Dis 1994;75:54-7.
91. Starke JR, Taylor-Watts KT. Tuberculosis in the pediatric population of Houston, Texas. Pediatrics 1989; 84:28-35.
92. Mehnaz A, Arif F. Applicability of scoring chart in the early detection of tuberculosis in children. J Coll Physicians Surg Pak 2005;15:543-6.
93. Raqib R, Rahman J, Kamaluddin AK, Kamal SM, Banu FA, Ahmed S et al. Rapid diagnosis of active tuberculosis by detecting antibodies from lymphocyte secretions. J Infect Dis 2003;188:364-70.